News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
SCHOEMAKER KATHLEEN K
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/20/2015 |
4
| DP VII ASSOCIATES LP (10% Owner) has filed a Form 4 on Evoke Pharma Inc|
Txns:
| Sold 202 shares
@ $7.02, valued at
$1.4k
|
|
| 08/20/2015 |
4
| DOMAIN PARTERS VII L P (10% Owner) has filed a Form 4 on Evoke Pharma Inc|
Txns:
| Sold 11,836 shares
@ $7.02, valued at
$83.1k
|
|
| 07/01/2015 |
4
| Domain Partners VIII, L.P. (10% Owner) has filed a Form 4 on GLAUKOS Corp|
Txns:
| Converted 876,083 shares
@ $0
Converted 589,100 preferred shares
@ $0
Converted 286,983 preferred shares
@ $0 |
|
| 07/01/2015 |
4
| DP VIII Associates, L.P. (10% Owner) has filed a Form 4 on GLAUKOS Corp|
Txns:
| Converted 6,501 shares
@ $0
Converted 4,371 preferred shares
@ $0
Converted 2,130 preferred shares
@ $0 |
|
| 07/01/2015 |
4
| DOMAIN PARTNERS IV LP (10% Owner) has filed a Form 4 on GLAUKOS Corp|
Txns:
| Converted 2,057,190 shares
@ $0
Paid exercise price by delivering 8,700 shares
@ $18, valued at
$156.6k
Converted 585,958 preferred shares
@ $0
Converted 925,926 preferred shares
@ $0
Converted 440,178 preferred shares
@ $0
Converted 105,128 preferred shares
@ $0
Exercised 20,470 warrants
@ $7.65, valued at
$156.6k
|
|
| 07/01/2015 |
4
| DP IV ASSOCIATES LP (10% Owner) has filed a Form 4 on GLAUKOS Corp|
Txns:
| Converted 14,041 shares
@ $0
Converted 14,041 preferred shares
@ $0 |
|
| 05/12/2015 |
4
| DP VIII Associates, L.P. (10% Owner) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Converted 13,414 shares
@ $0
Converted 90,110 preferred shares
@ $0
Converted 11,182 preferred shares
@ $0
Converted 6,581 preferred shares
@ $0 |
|
| 05/12/2015 |
4
| Domain Partners VIII, L.P. (10% Owner) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Converted 1,807,820 shares
@ $0
Converted 12,143,933 preferred shares
@ $0
Converted 1,506,901 preferred shares
@ $0
Converted 887,073 preferred shares
@ $0 |
|
| 05/11/2015 |
4
| DP VI Associates, L.P. (10% Owner) has filed a Form 4 on CoLucid Pharmaceuticals, Inc.|
Txns:
| Converted 3,519 shares
@ $0
Converted 1,954 preferred shares
@ $0
Converted 1,565 preferred shares
@ $0 |
|
| 05/11/2015 |
4
| Domain Partners VI, L.P. (10% Owner) has filed a Form 4 on CoLucid Pharmaceuticals, Inc.|
Txns:
| Converted 2,202,233 shares
@ $0
Converted 798,188 preferred shares
@ $0
Converted 939,289 preferred shares
@ $0
Converted 464,756 preferred shares
@ $0 |
|
| 05/06/2015 |
4
| DOMAIN ASSOCIATES (10% Owner) has filed a Form 4 on Tibira Therapeutics, Inc.|
Txns:
| Acquired 36,187 shares
@ $0 |
|
| 05/06/2015 |
4
| DOMAIN PARTERS VII L P (10% Owner) has filed a Form 4 on Regado Biosciences Inc|
Txns:
| Bought 277,777 shares
@ $10.62, valued at
$2.9M
|
|
| 04/16/2015 |
4
| DOMAIN PARTERS VII L P (10% Owner) has filed a Form 4 on Evoke Pharma Inc|
Txns:
| Sold 9,832 shares
@ $7.78, valued at
$76.5k
Sold 7,920 shares
@ $7.58, valued at
$60k
Sold 32,411 shares
@ $7.07, valued at
$229.1k
|
|
| 04/16/2015 |
4
| DP VII ASSOCIATES LP (10% Owner) has filed a Form 4 on Evoke Pharma Inc|
Txns:
| Sold 168 shares
@ $7.78, valued at
$1.3k
Sold 135 shares
@ $7.58, valued at
$1k
Sold 554 shares
@ $7.07, valued at
$3.9k
|
|
| 03/24/2015 |
4
| DOMAIN PARTERS VII L P (10% Owner) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Disposed of 350,000 shares
@ $0 |
|
| 12/10/2014 |
4/A
| DP VII ASSOCIATES LP (10% Owner) has filed a Form 4 on Neothetics, Inc.|
Txns:
| Converted 46,311 shares
@ $0
Paid exercise price by delivering 958 shares
@ $14, valued at
$13.4k
Paid exercise price by delivering 1,725 shares
@ $14, valued at
$24.2k
Converted 12,578 preferred shares
@ $0
Converted 104,247 preferred shares
@ $0
Converted 36,913 preferred shares
@ $0
Converted 102,282 preferred shares
@ $0
Exercised 1,570 options to buy
@ $8.54, valued at
$13.4k
Exercised 2,827 options to buy
@ $8.54, valued at
$24.1k
|
|
| 12/10/2014 |
4/A
| DOMAIN PARTERS VII L P (10% Owner) has filed a Form 4 on Neothetics, Inc.|
Txns:
| Converted 2,921,065 shares
@ $0
Paid exercise price by delivering 56,185 shares
@ $14, valued at
$786.6k
Paid exercise price by delivering 101,132 shares
@ $14, valued at
$1.4M
Bought 70,000 shares
@ $14, valued at
$980k
Converted 737,422 preferred shares
@ $0
Converted 6,111,968 preferred shares
@ $0
Converted 2,164,305 preferred shares
@ $0
Converted 7,252,144 preferred shares
@ $0
Exercised 92,105 options to buy
@ $8.54, valued at
$786.6k
Exercised 165,790 options to buy
@ $8.54, valued at
$1.4M
|
|
| 11/26/2014 |
4
| DP VII ASSOCIATES LP (10% Owner) has filed a Form 4 on Neothetics, Inc.|
Txns:
| Converted 46,309 shares
@ $0
Paid exercise price by delivering 958 shares
@ $14, valued at
$13.4k
Paid exercise price by delivering 1,725 shares
@ $14, valued at
$24.2k
Converted 12,578 preferred shares
@ $0
Converted 104,247 preferred shares
@ $0
Converted 36,913 preferred shares
@ $0
Converted 102,282 preferred shares
@ $0
Exercised 1,570 options to buy
@ $8.54, valued at
$13.4k
Exercised 2,827 options to buy
@ $8.54, valued at
$24.1k
|
|
| 11/26/2014 |
4
| DOMAIN PARTERS VII L P (10% Owner) has filed a Form 4 on Neothetics, Inc.|
Txns:
| Converted 2,921,064 shares
@ $0
Paid exercise price by delivering 56,185 shares
@ $14, valued at
$786.6k
Paid exercise price by delivering 101,132 shares
@ $14, valued at
$1.4M
Bought 70,000 shares
@ $14, valued at
$980k
Converted 737,422 preferred shares
@ $0
Converted 6,111,968 preferred shares
@ $0
Converted 2,164,305 preferred shares
@ $0
Converted 7,252,144 preferred shares
@ $0
Exercised 92,105 options to buy
@ $8.54, valued at
$786.6k
Exercised 165,790 options to buy
@ $8.54, valued at
$1.4M
|
|
| 11/18/2014 |
4
| Domain Partners VIII, L.P. (10% Owner) has filed a Form 4 on Durata Therapeutics, Inc.|
Txns:
| Disposed/sold 3,006,132 shares
@ $0
Disposed/sold 3,006,132 shares
@ $0 |
|
| 11/18/2014 |
4
| DP VIII Associates, L.P. (10% Owner) has filed a Form 4 on Durata Therapeutics, Inc.|
Txns:
| Disposed/sold 22,306 shares
@ $0 |
|
| 11/18/2014 |
4
| DOMAIN ASSOCIATES (10% Owner) has filed a Form 4 on Durata Therapeutics, Inc.|
Txns:
| Disposed/sold 6,250 shares
@ $0 |
|
| 10/21/2014 |
4
| DOMAIN PARTERS VII L P (10% Owner) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Bought 500,000 shares
@ $20, valued at
$10M
|
|
| 10/21/2014 |
4
| DP VIII Associates, L.P. (10% Owner) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Converted 14,049 shares
@ $0
Bought 1,841 shares
@ $11, valued at
$20.3k
Converted 9,443 preferred shares
@ $0
Converted 4,606 preferred shares
@ $0 |
|
| 10/21/2014 |
4
| Domain Partners VIII, L.P. (10% Owner) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Converted 1,893,383 shares
@ $0
Bought 248,159 shares
@ $11, valued at
$2.7M
Converted 1,272,607 preferred shares
@ $0
Converted 620,776 preferred shares
@ $0 |
|
| 09/12/2014 |
4
| Domain Partners VIII, L.P. (10% Owner) has filed a Form 4 on VERACYTE, INC.|
Txns:
| Disposed of 300,000 shares
@ $0 |
|
| 08/18/2014 |
4
| DP VIII Associates, L.P. (10% Owner) has filed a Form 4 on Otonomy, Inc.|
Txns:
| Converted 11,490 shares
@ $0
Paid exercise price by delivering 277 shares
@ $16, valued at
$4.4k
Converted 3,238 preferred shares
@ $0
Converted 6,866 preferred shares
@ $0
Paid exercise price by delivering 1,386 preferred shares
@ $0
Exercised 502 options to buy
@ $8.79, valued at
$4.4k
|
|
| 08/18/2014 |
4
| Domain Partners VIII, L.P. (10% Owner) has filed a Form 4 on Otonomy, Inc.|
Txns:
| Converted 1,548,792 shares
@ $0
Paid exercise price by delivering 37,224 shares
@ $16, valued at
$595.6k
Converted 436,485 preferred shares
@ $0
Converted 925,479 preferred shares
@ $0
Paid exercise price by delivering 186,828 preferred shares
@ $0
Exercised 67,755 options to buy
@ $8.79, valued at
$595.6k
|
|
| 08/07/2014 |
4
| DP VI Associates, L.P. (10% Owner) has filed a Form 4 on MARINUS PHARMACEUTICALS INC|
Txns:
| Converted 17,000 shares
@ $0
Converted 8,792 preferred shares
@ $0
Converted 7,043 preferred shares
@ $0
Converted 1,165 preferred shares
@ $0 |
|
| 08/07/2014 |
4
| Domain Partners VI, L.P. (10% Owner) has filed a Form 4 on MARINUS PHARMACEUTICALS INC|
Txns:
| Converted 2,057,142 shares
@ $0
Bought 419,744 shares
@ $8, valued at
$3.4M
Converted 820,320 preferred shares
@ $0
Converted 657,192 preferred shares
@ $0
Converted 579,630 preferred shares
@ $0 |
|
| 05/07/2014 |
4
| Domain Partners VI, L.P. (10% Owner) has filed a Form 4 on Aldeyra Therapeutics, Inc.|
Txns:
| Converted 21,250 shares
@ $0
Converted convertible notes
@ $8, valued at
$0 |
|
| 05/05/2014 |
4
| DP VI Associates, L.P. (10% Owner) has filed a Form 4 on Aldeyra Therapeutics, Inc.|
Txns:
| Converted 9,208 shares
@ $0
Converted 3,882 preferred shares
@ $0 |
|
| 05/05/2014 |
4
| Domain Partners VI, L.P. (10% Owner) has filed a Form 4 on Aldeyra Therapeutics, Inc.|
Txns:
| Converted 1,909,113 shares
@ $0
Paid exercise price by delivering 39,063 shares
@ $8, valued at
$312.5k
Converted 486,316 preferred shares
@ $0
Converted 755,263 preferred shares
@ $0
Exercised 60,576 options to buy
@ $5.16, valued at
$312.6k
|
|
| 03/21/2014 |
4
| SCHOEMAKER KATHLEEN K (10% Owner) has filed a Form 4 on CADENCE PHARMACEUTICALS INC|
Txns:
| Disposed/sold 2,972,678 shares
@ $14, valued at
$41.6M
Disposed/sold 50,743 shares
@ $14, valued at
$710.4k
Disposed/sold 7,313,241 shares
@ $14, valued at
$102.4M
Disposed/sold 78,369 shares
@ $14, valued at
$1.1M
Disposed/sold 27,500 shares
@ $14, valued at
$385k
|
|
|
|
|